Biotech Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 25, 2022
Biotech Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults July 25, 2022
Biotech The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations July 25, 2022
Biotech Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million July 25, 2022
Biotech Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022 July 25, 2022
Biotech Cocrystal Pharma Reports CC-42344 Pharmacokinetic Data in Influenza A Once-Daily Dosing July 25, 2022
Biotech GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil July 25, 2022